Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Biocompatibility Testing Services Market size was valued US$ 664 million in 2023 and is poised to grow at a CAGR of 12.1% 2024-2030. Due to increase in the research for the discovery of various types of medical devices. Moreover, due to the prevalence of various life threatening diseases, various new drugs and new devises are coming into the market those new products or devices need to be compatible with the human body, plastics and other polymers intended for use in medical devices, implants or other systems associated with a medical process, must be shown to be compatible with the human body these are the major factors that are driving the growth of the market over the forecast timeframe. An increase in the prevalence of various diseases such as cardiovascular diseases is a key factor drive.
According to World Health Organization, approximately 17.9 Mn death occurred due to cardiovascular diseases around the globe represents 31% of deaths around the globe and many people in developed countries are using heart stents and other medical devices to extend their lives for few more years. Moreover, these medical devices which are implanted in the human body must be biocompatible and the material that they use to make these devices like plastics, polymers also need to be biocompatible otherwise serious adverse effects may occur which may cause in death of the patient so biocompatibility testing should be performed and the raise in funding for the R&D activities by public and private sectors are anticipated to propel the market over the forecast years.
Study Period
2024-2030Base Year
2023CAGR
12.1%Largest Market
Asia-PacificFastest Growing Market
North-America
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 664 million |
Market CAGR |
12.1% |
By Type |
|
By Region |
|
Download Free Sample Report
The global biocompatibility testing services market size was valued at US$ 664 million in 2023 and is projected to grow at a CAGR of 12.1% from 2024-2030.
The Biocompatibility Testing Services Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Biocompatibility Testing Services Market key players Wickham Laboratories, North American Science Associates Inc., GLR Laboratories Pvt Ltd., Accuprec Research Labs Pvt. Ltd., Nelson Laboratories, Inc., Toxikon, Inc., Pacific BioLabs BioComp Laboratories, Inc., Morulaa HealthTech Pvt. Ltd., Geneva Laboratories
Key Market Players